⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

Sermorelin

Published Research

PubMed-indexed studies for Sermorelin

Research

Advances in the detection of growth hormone releasing hormone synthetic analogs.

Drug testing and analysis 2021
View on PubMed →
Research

Growth hormone releasing hormone.

Clinics in endocrinology and metabolism 1986
View on PubMed →
Research

Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999
View on PubMed →
Research

Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.

International journal of molecular sciences 2025
View on PubMed →
Research

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.

Proceedings of the National Academy of Sciences of the United States of America 2011
View on PubMed →
Research

Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH).

The Prostate 2022
View on PubMed →

Research-Grade Sermorelin

YPB.211
Sermorelin (10mg)
$80.00
⚠️ For laboratory research only. Not for human use.